You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
復星醫藥(02196.HK):擬出資4000萬元參與認購私募股權投資基金份額
格隆匯 01-27 18:06

格隆匯1月27日丨復星醫藥(02196.HK)公佈,2022年1月27日,公司與南京巍奕、上海銨普、南京江北星創基金以及上海巍奕簽訂《目標基金合夥協議》,公司擬作為LP現金出資人民幣4,000萬元認繳目標基金等值財產份額,約佔目標基金首輪募集總額的40%。公司將以自籌資金支付此次投資的款項。

基金投資領域:醫藥研發、醫學診斷、醫療器械、醫療服務、大健康等領域的創新型優質企業的直接或間接的股權投資或可轉股債權投資。投資標的應主要為初創、小微、成長等不同性質和發展階段的科技企業及平台,重點投資處於天使、初創期的科技創新項目。

公吿稱,此次投資旨在獲取投資回報,並拓展集團與醫藥研發、醫學診斷、醫療器械等大健康領域的初創型科技企業和平台的合作機會。此次投資完成後,目標基金不會納入本集團合併報表範圍。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account